These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 8582238)

  • 21. Flow cytometric analysis of proliferation associated nuclear antigens using washless staining of unfixed cells.
    Landberg G; Roos G
    Cytometry; 1992; 13(3):230-40. PubMed ID: 1374305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trivariate flow cytometric analysis of paraffin-embedded lung cancer specimens: application of cytokeratin subtype specific antibodies to distinguish between differentiation pathways.
    Leers MP; Theunissen PH; Koudstaal J; Schutte B; Ramaekers FC
    Cytometry; 1997 Feb; 27(2):179-88. PubMed ID: 9012385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Flow cytometric techniques for measurement of proliferating cell nuclear antigen (PCNA)].
    Ichikawa A; Shimamura K; Koyama Y
    Nihon Rinsho; 1992 Oct; 50(10):2343-8. PubMed ID: 1360029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin-embedded tissues.
    Corver WE; Ter Haar NT; Dreef EJ; Miranda NF; Prins FA; Jordanova ES; Cornelisse CJ; Fleuren GJ
    J Pathol; 2005 Jun; 206(2):233-41. PubMed ID: 15822070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor cell-selective flow cytometric analysis for DNA content and cytokeratin expression of clinical tumor specimens by "cross-gating".
    Park CH; Kimler BF
    Anticancer Res; 1994; 14(1A):29-36. PubMed ID: 7513144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of suramin on expression of proliferation associated nuclear antigens in DU-145 prostate carcinoma cells.
    Qiao L; Pizzolo JG; Melamed MR
    Biochem Biophys Res Commun; 1994 Jun; 201(2):581-8. PubMed ID: 7911660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometric DNA analysis of breast cancer by two colour method using cytokeratin labeling for identification of tumour cells.
    Kimmig R; Spelsberg H; Kapsner T; Untch M; Hepp H
    Anal Cell Pathol; 1994 Oct; 7(3):205-15. PubMed ID: 7531483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of proliferation activities in human tumor models: a comparison of flow cytometric methods.
    Keng PC; Siemann DW
    Radiat Oncol Investig; 1998; 6(3):120-7. PubMed ID: 9652910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometry of mitotic cells.
    Anderson HJ; de Jong G; Vincent I; Roberge M
    Exp Cell Res; 1998 Feb; 238(2):498-502. PubMed ID: 9473359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.
    Uchiyama B; Saijo Y; Kumano N; Abe T; Fujimura S; Ohkuda K; Handa M; Satoh K; Nukiwa T
    Clin Cancer Res; 1997 Oct; 3(10):1873-7. PubMed ID: 9815576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Options of flow cytometric three-colour DNA measurements to quantitate EGFR in subpopulations of human bladder cancer.
    Brockhoff G; Endl E; Minuth W; Hofstädter F; Knüchel R
    Anal Cell Pathol; 1996 Jun; 11(1):55-70. PubMed ID: 8844105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear autoantigen p330d/CENP-F: a marker for cell proliferation in human malignancies.
    Landberg G; Erlanson M; Roos G; Tan EM; Casiano CA
    Cytometry; 1996 Sep; 25(1):90-8. PubMed ID: 8875058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric analysis of the kinetic effects of cisplatin on lung cancer cells.
    Fujikane T; Shimizu T; Tsuji T; Ishida S; Ohsaki Y; Onodera S
    Cytometry; 1989 Nov; 10(6):788-95. PubMed ID: 2582970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ki-67 labeling indices in non-small cell lung cancer: comparison between image cytometry and flow cytometry.
    Ishikuro A; Dosaka-Akita H; Kato M; Fujino M; Isobe H; Miyamoto H; Inoue K; Kawakami Y
    Cytometry; 1997 Aug; 30(4):186-91. PubMed ID: 9298837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.
    Bellotti M; Elsner B; Paez De Lima A; Esteva H; Marchevsky AM
    Mod Pathol; 1997 Dec; 10(12):1221-7. PubMed ID: 9436967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of correlation between flow cytometric and immunohistologic proliferation measurements of tumors.
    Linden MD; el-Naggar AK; Nathanson SD; Jacobson G; Zarbo RJ
    Mod Pathol; 1996 Jun; 9(6):682-9. PubMed ID: 8782208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative flow cytometric analysis of DNA-bound PCNA and DNA content as estimators of S-phase cells in cell cultures.
    Bustamante AS; Guervós MA; de los Toyos JR; Dolbeare F; Sampedro A
    Anal Cell Pathol; 1996 Jul; 11(2):127-36. PubMed ID: 8844110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of proliferation markers and their prognostic value for women with endometrial carcinoma. Ki-67, proliferating cell nuclear antigen, and flow cytometric S-phase fraction.
    Nordström B; Strang P; Bergström R; Nilsson S; Tribukait B
    Cancer; 1996 Nov; 78(9):1942-51. PubMed ID: 8909315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A simple method for flow cytometric measurement of Ki-67 reactive antigen on small solid tissues].
    Murakami T; Oga A; Uchiyama T; Kimura Y; Morimoto H; Suzuki T; Takahashi M
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):737-40. PubMed ID: 7683864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Giant cell tumor of bone. Morphological, immunohistochemical, morphometric and DNA flow cytometric findings].
    Kröber SM; Greschniok A; Böhm P; Kaiserling E
    Verh Dtsch Ges Pathol; 1998; 82():279-83. PubMed ID: 10095447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.